Neuroendocrine tumors history and symptoms: Difference between revisions
Jump to navigation
Jump to search
No edit summary |
|||
| Line 1: | Line 1: | ||
__NOTOC__ | __NOTOC__ | ||
{{Neuroendocrine tumors}} | {{Neuroendocrine tumors}} | ||
Please help WikiDoc by adding more content here. It's easy! Click [[Help:How_to_Edit_a_Page|here]] to learn about editing. | |||
{{CMG}} | {{CMG}} | ||
| Line 26: | Line 29: | ||
==References== | ==References== | ||
{{Reflist|2}} | {{Reflist|2}} | ||
[[Category:Needs content]] | |||
{{WH}} | {{WH}} | ||
{{WS}} | {{WS}} | ||
Revision as of 20:58, 30 August 2012
|
Neuroendocrine tumors Microchapters |
Please help WikiDoc by adding more content here. It's easy! Click here to learn about editing.
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]
Overview
History
Symptoms
According to Arnold et alia, "many tumors are asymptomatic even in the presence of metastases" (Arnold et al. 2004, 197).
A carcinoid tumor may produce serotonin (5-HT), a biogenic amine that causes a specific set of symptoms including
- Flushing
- Diarrhea or increase in number of bowel movements
- Weight loss
- Weight gain
- Palpitations
- Congestive heart failure (CHF)
- Asthma
- Acromegaly
- Cushing's syndrome
This set of symptoms is called Carcinoid syndrome.